HG-14-10-04 25 mg | Purity Not Available
TargetMol
HG-14-10-04
Search Results
BTB-1 25 mg | 99.71%
TargetMol
BTB-1 (NSC156750) is a novel small molecule inhibitor of the mitotic motor protein Kif18A.
More Information Supplier PageBTB-1
BTB-1 5 mg | 99.71%
TargetMol
BTB-1 (NSC156750) is a novel small molecule inhibitor of the mitotic motor protein Kif18A.
More Information Supplier PageBTB-1
ML329 2 mg | Purity Not Available
TargetMol
ML329 is a small molecule inhibitor of MITF, inhibiting TRPM-1 promoter activity.
More Information Supplier PageML329
QS11 25 mg | 98.39%
TargetMol
QS11 is a GTPase activating protein of ADP-ribosylation factor 1 (ARFGAP1) inhibitor. Modulates ARF-GTP levels and synergizes with the Wnt/β-catenin signaling pathway to upregulate β-catenin nuclear translocation. Also reduces in vitro migration of metastatic human breast cancer cells.
More Information Supplier PageQS11
QS11 2 mg | 98.39%
TargetMol
QS11 is a GTPase activating protein of ADP-ribosylation factor 1 (ARFGAP1) inhibitor. Modulates ARF-GTP levels and synergizes with the Wnt/β-catenin signaling pathway to upregulate β-catenin nuclear translocation. Also reduces in vitro migration of metastatic human breast cancer cells.
More Information Supplier PageQS11
Relebactam 10 mg | Purity Not Available
TargetMol
Relebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases.
More Information Supplier PageRelebactam
BMS-986020 25 mg | 98.61%
TargetMol
BMS-986020
BTZ043 25 mg | 99.69%
TargetMol
BTZ043 is a DprE1 inhibitor with nanomolar bactericidal activity against Mycobacterium tuberculosis in vitro.
More Information Supplier PageBTZ043
Resmetirom 2 mg | 99.05%
TargetMol
Resmetirom (VIA-3196) is a highly selective thyroid hormone receptor β (THR-β) agonist.
More Information Supplier PageResmetirom
